Immunome (IMNM) Non-cash Items (2019 - 2026)

Immunome has reported Non-cash Items for 8 years, with the latest figure at $6.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 78.55% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (up 78.55% YoY), and the FY2025 full-year result was $5.7 million, down 83.25% from the prior year.
• Non-cash Items for Q1 2026 stood at $6.4 million, down from $180.7 million in the prior quarter.
• The five-year high for Non-cash Items was $180.7 million in Q4 2025, with the low at $779707.0 in Q1 2022.
• Historically, Non-cash Items has averaged $23.0 million across 5 years, with a median of $5.0 million in 2025.
• Annual changes were most pronounced in 2023 — Non-cash Items surged 4940.0% — and 2025, when it slumped 93.11%.
• Immunome's Non-cash Items stood at $900000.0 in 2022, then surged by 4940.0% to $45.4 million in 2023, then dropped by 24.58% to $34.2 million in 2024, then jumped by 428.13% to $180.7 million in 2025, then plunged by 96.48% to $6.4 million in 2026.
• The last three Non-cash Items figures came in at $6.4 million (Q1 2026), $180.7 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.